🔎 Trials Near Me

Home › Myelofibrosis › Utah › Salt Lake City

Myelofibrosis clinical trials in Salt Lake City, UT

10 studies for Myelofibrosis are looking for participants at sites in and around Salt Lake City (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis

RecruitingPhase 1/2
  • Huntsman Cancer Institute, Salt Lake City
Ages 18 and older · All sexes · Updated Oct 2, 2026 · NCT04176198

Tolerability of Ropeginterferon Alfa-2b Add-on to Ongoing Ruxolitinib Therapy in Myelofibrosis

RecruitingPhase 1
  • Huntsman Cancer Institute at University of Utah, Salt Lake City
Ages 18 and older · All sexes · Updated Oct 1, 2026 · NCT07521046

A Randomized Study of ASTX727 With or Without Iadademstat in Advanced Myeloproliferative Neoplasms (MPNs)

RecruitingPhase 2
  • Huntsman Cancer Institute/University of Utah, Salt Lake City
Ages 18 and older · All sexes · Updated Sep 30, 2026 · NCT06661915

A Study to Evaluate INCA035784 in Participants With Myeloproliferative Neoplasms

RecruitingPhase 1
  • Huntsman Cancer Institute At University of Utah, Salt Lake City
Ages 18 and older · All sexes · Updated Aug 6, 2026 · NCT07008118

Study of INCA036978 in Participants With Myeloproliferative Neoplasms

RecruitingPhase 1
  • Huntsman Cancer Institute, Salt Lake City
Ages 18 and older · All sexes · Updated Jul 22, 2026 · NCT07441694

AlloHCT With PegINFa for Myelofibrosis

RecruitingPhase 1
  • Huntsman Cancer Institute at the University of Utah, Salt Lake City
Ages 18 and older · All sexes · Updated Jun 4, 2026 · NCT05535764

Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.

RecruitingPhase 1
  • University of Utah, Salt Lake City
Ages 13 and older · All sexes · Updated May 5, 2026 · NCT04771572

A Study of Selinexor Monotherapy in Subjects With JAK Inhibitor-naïve Myelofibrosis and Moderate Thrombocytopenia

RecruitingPhase 2
  • Huntsman Cancer Institute, Salt Lake City
Ages 18 and older · All sexes · Updated Feb 12, 2026 · NCT05980806

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

RecruitingObservational study
  • Massive Bio SYNERGY-AI site, Salt Lake City
All ages · All sexes · Updated Oct 28, 2025 · NCT03452774

Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib

RecruitingPhase 3
  • University of Utah, Huntsman Cancer Institute, Salt Lake City
Ages 18 and older · All sexes · Updated Sep 25, 2025 · NCT06479135

Myelofibrosis trials in other cities

Other studies in Salt Lake City

From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.